Total Results: 7179

HHS Study: Medicaid Expansion Could Lead To Lower Premiums For Everyone

Department of Health and Human Services researchers compared counties across state borders and adjusted for several differences between them. Their calculations led them to conclude that expanding Medicaid helped produce to marketplace premiums that were 7 percent lower.

EpiPen’s Soaring Price Tag Leads To More Debate, Discussion Of U.S. Drug Costs

A Sonoma Country family feels the pinch of the high price of this emergency allergy medicine. Meanwhile, news outlets explore recent developments such as the response by Mylan, the company that markets the EpiPen, as well as positions being taken by lawmakers, parents, public figures and even Mylan’s CEO.

Proposition 61 Offers State One More Chance To Rein In Drug Prices

As the national controversy continues surrounding the high cost of EpiPens — the most recent to focus attention on drug costs, the San Francisco Chronicle reports on this November ballot measure, which would prohibit state agencies from paying more for drugs than does the U.S. Department of Veterans Affairs.